Ibrutinib-related skin cancer: A pharmacovigilance study from the Food and Drug Administration Adverse Event Reporting System.

HOME
>
論文・技術情報
>
Ibrutinib-related skin cancer: A pharmacovigilance study from the Food and Drug Administration Adverse Event Reporting System.

アブストラクト
ジャーナル名	European journal of cancer (Oxford, England : 1990)
Pubmed追加日	2021/12/7
投稿者	Sun, Ximu; Ma, Zhuo; Guo, Qixiang; Zhao, Zhixia; Liu, Lihong
組織名	Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, 8;Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, China; Department of;Pharmacy, Beijing Obstetrics and Gynecology Hospital, Capital Medical University,;No.17, Qi He Lou Street, Dongcheng District, Beijing, China.;Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, China.;Gongren Tiyuchang Nanlu, Chaoyang District, Beijing, China. Electronic address:;zhixia.1002@163.com.;Department of Pharmacy, China-Japan Friendship Hospital, No.2 Yinghuayuan;Dongjie, Chaoyang District, Beijing, China. Electronic address:;liulihong@bjcyh.com.
Pubmed リンク	https://www.ncbi.nlm.nih.gov/pubmed/34865944/